Science Behind Alzheimer´S Disease And Parkinson´S Disease

1078 words - 5 pages

Alzheimer’s disease (AD)
In fact, the pathology of Aβ and tau in AD is not fully elucidated, it has been implied that intracellular Aβ oligomers impaired the proteasome activity which is contributing to the age-related pathological accumulation of Aβ and tau in AD mice model when Aβ oligomer levels are high (Tseng et al., 2008). Together with Aβ, tau which is an intrinsically unstructured protein associated with microtubules also involves in the pathology of AD (Lee et al., 2013; Selkoe, 2011). Whether the significance of Ub-independent and Ub-dependent degradation of tau within the cell through the UPS and autophagy is contradictory, accumulation of ubiquitin positive tau tangle, association of tau with diverse proteasome subunits and identifications of poly-ubiquitylated tau in different K-linkages (K6-, K11-, K48- and K63-linkages) have been suggested to the association of the cellular degradation machineries in AD (Lee et al., 2013). In parallel role of autophagy as a second line of the UPS also has been suggested that soluble tau is degraded via the UPS, whereas oligomeric tau aggregates are efficiently degraded through the autophagy-lysosomal system (Kruger et al., 2012; Lee et al., 2013; Wang and Mandelkow, 2012).
Post-modification of tau also influences the formation of tau aggregates. Acetylation of tau by histone acetyl-transferase p300 prevents degradation of phosphorylated tau and reversely, deficiency of deacetylase SIRT1 enhanced levels of acetylated-tau aggregation (Cohen et al., 2011; Min et al., 2010). Furthermore, the identification of Hsp90-CHIP complex selectively degrades phosphorylated tau propose the active role of the UPS on elimination of the aberrant tau protein (Dickey et al., 2007; Salminen et al., 2011). Presumably, the modulation of tau state or regulation of E3 ligase CHIP activity could be one of the therapeutic strategies to reduce proteostasis imbalanced in tau-mediated AD.

Parkinson’s disease (PD)
The formation of lewy bodies which often consist of α-synuclein, PARKIN and the UPS components together in dopaminergic neurons of the substantia nigra (SN) is the common hallmark of PD and accumulation of toxic oligomeric α-synuclein and a mutation of E3 ligase PARKIN (PARK2) and in the deubiquitinase UCHL1 contributes the pathology of PD (Ardley et al., 2004). Interestingly, both wild-type and mutant forms of α-synuclein oligomer has the ability to inhibit proteasomal function in vitro with a dose-dependent manner (Lindersson et al., 2004) and overexpression of A53T mutation in α-synuclein further aggravates proteasomal degradation in vivo (Emmanouilidou et al., 2010; Nonaka and Hasegawa, 2009).
While a recent study has suggested that α-synuclein is as a helically folded tetramer which devoid amyloid-like aggregation (Bartels et al., 2011), as like tau, monomeric α-synuclein has been believed an intrinsically unfolded monomer and it could be degraded by the proteasome without ubiquitin conjugation...

Find Another Essay On Science Behind Alzheimer´s Disease and Parkinson´s Disease

Alzheimer´s Disease and Symptomatic Relief Drugs

877 words - 4 pages The cognition-enhancing effects of a particular drug may offer only symptomatic relief against AD. These effects need to be considered separately from other possible neuroprotective/neurorestorative effects. Compounds that exhibit the latter characteristics are designed to alter the progression and course of the disease by improving brain function by facilitating recovery or preventing neuronal cell loss. A notable example is P7C3, a 5-HT6

What is Alzheimer´s Disease? Essay

1445 words - 6 pages by the time they die. People suffering from Alzheimer's are emotionally dead long before the physically die. Eventually science will discover exactly why this terrible disease occurs and there will be prevention and recovery methods but until then it’s important to know the signs and keep your mind vigilant. Works Cited 1. 2. 3. http

Facts About Alzheimer´s Disease

1276 words - 6 pages experiment situations in examining the role of Ach in visual processing. The brain ACH systems rely on understanding and physical input in early development. According to Yankner, in the 1990s described how the plaque deposits that form in the Alzheimer’s patients are toxic (2014). The individuals who develop Alzheimer disease regularly experience a widespread variety and mix of emotions, they are commonly confused, irritated, annoyed and

Alzheimer´s Disease and Its Relation with Dementia

748 words - 3 pages Alzheimer’s disease (AD) is a permanent condition that affects the brain. This condition progressively alters the working of nerve cells and ultimately leads to the death of brain cells. As a result, affected individuals lose the ability to remember even the most important details about themselves and their families. Alzheimer’s disease commonly occurs in individuals aged 65 years and above. Although most of the symptoms of this condition

A Drifing Mind: Alzheimer´s Disease

802 words - 4 pages The article I decided to go with was “Special Nursing Home Units for Residents with Primary Degenerative Dementia: Alzheimer's disease”. The reason I went with this article was because I wanted to focus on a different stage of life. I also have family that has had Alzheimer’s disease. I think this was one of the hardest things I have seen in my life. My aunt would remember my name one moment and forget I was even alive the next. The purpose of

Alzheimer´s Disease: What to Expect

627 words - 3 pages Clinical Features (Symptoms) Alzheimer’s disease is a progressive disease that gradually destroys brains cells affecting brain functions. Scientists explain that Alzheimer’s disease progresses on a spectrum with three stages from an early stage to a middle stage of mild cognitive impairment (MCI) and to a final stage of Alzheimer’s dementia. Not everyone experiences the same progress at the same rate and the symptoms will develop over the

Parkinson disease

1176 words - 5 pages dyskinesias. Surgery will be an effective treatment option in more advanced PD. Subthalamic nucleus deep brain stimulation has been used to improve motor function and alleviate motor complication, as a last resort in severe cases where drugs are ineffective.References:Davie CA (2008). "A review of Parkinson's disease". Br. Med. Bull. 86 (1): 109-27.Goodman, Louis S., Laurence L. Brunton, Bruce Chabner, and Björn C. Knollmann. Goodman & Gilman's

Parkinson Disease

1367 words - 5 pages Parkinson disease (PD), also referred to as Parkinson’s disease and paralysis agitans, is a progressive neurodegenerative disease that is the third most common neurologic disorder of older adults. It is a debilitating disease affecting motor ability and is characterized by four cardinal symptoms: tremor rigidity, bradykinesia or kinesis (slow movement/no movement), and postural instability. Most people have primary, or idiopathic, disease. A few

Insomnia and Alzheimer Disease

2840 words - 11 pages 1. A possible condition for insomnia is Alzheimer disease (AD). There is a risk of circadian rhythm disruption in people that may possibly have AD, because this leads to an increase in beta-amyloid plaques in the brain. This is related to cognitive loss as AD progresses (Kang et al, 2009). AD has no definitive test. Blood and urine samples are tested so other medical cases are ruled out. Doctors usually do various tests based on patient’s memory

Alzheimer´s Disease: An in Depth Look at Signs, Symptoms, and Disgnosis

741 words - 3 pages , they lose the ability to smile or sit without support. Diagnosis of Alzheimer’s disease is not an exact science. Certain tests are completed to assist in the diagnosis. These tests include; mental status testing, neurological exam and thorough medical history, physical tests are also completed. There are no current treatments for Alzheimer’s disease. Researchers are constantly looking for new and advanced treatments to alter the course. Any breakthrough in progress will ensure the improvement of the quality of life of people with dementia. Works Cited

Parkinson Disease (PD)

2728 words - 11 pages . Jr. Marks, Phillip A. Starr, 2000. Deep brain stimulation for advanced parkinsons disease. AORN Journal. 6. Figure 1. Downloaded on 14-2-2011. 7. Figure 2. Yin et al, 2006. Nature Reviews Neuroscience 7, 464–476. 8. Figure 3 Downloaded on 13-2-2011. 9. Figure 4.

Similar Essays

Parkinson´S Disease Essay

1734 words - 7 pages ancient Egypt, and it has also made an appearance in the Christian Bible. There is no clear evidence of it until the 17th century (All About Parkinson's Disease). Even though it has been here for a while now, the disease was not always called Parkinson’s. In fact it was called paralysis agitans or shaking palsy when James Parkinson wrote an essay on it. It is thought that he was the first to discuss Parkinson’s disease and it was later renamed to

Dementia And Alzheimer´S Disease Essay

1970 words - 8 pages 1. Throughout this line of study, Alzheimer’s disease is a specific form of dementia. According to Alzheimer’s Association, dementia is a general term for a decline in mental ability that is severe enough to hinder daily life. Memory loss is a symptom of dementia and the most common type of dementia is Alzheimer’s. One of the most common and severe symptom of Alzheimer’s is difficulty remembering newly learned information. The changes of

What Is Parkinson´S Disease? Essay

1190 words - 5 pages diseases and it is important to inspect the neural structures that are affected as well as the possible pathogenesis, in order to determine what the syndrome may be. Parkinson’s disease (PD) is a progressive syndrome of the CNS that plagues the elderly and has been seen to be more prominent in the male population than the female population (Lees et al., 2009). This disease is a challenging and pervasive syndrome and unfortunately, there are not any

Alzheimer´S Disease And Pet Imaging Essay

1038 words - 5 pages Alzheimer’s disease (AD) is an irreversible neurodegenerative disorder that progressively hinders cognitive and behavioral abilities. In individuals affected by the disease, cognitive decline is manifested by the impairment of memory, reasoning, judgement, visuospatial ability and language functions1. Behaviorally, unpredictable changes in personality become readily pronounced1. Corollary to the symptoms, the pathogenesis of AD is complex and